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Isolated proximal anomalous connections of the coronary arteries
(ANOCOR) are rare and sometimes raise diagnostic and therapeutic problems.
The prognosis depends mainly on the initial course of the ectopic vessel. In
the current guidelines, surgical repair is recommanded for high risk
ANOCOR. The lack of controlled studies and scarcity of data concerning the
long-term evaluation of ANOCOR corrected or not may explain the discor-
dance noticed between recommandations and practices. Large-scale prospec-
tive multicenter registries dedicated to ANOCOR are needed to achieve a
better understanding of the clinical profile and the impact of correction on the
natural history of these congenital coronary abnormalities.
The ANOCOR study began 31st January, 2010 with an inclusion period of
3 years. More than 450 young people (≥15-year-old) and adults have been included
by 71 interventional cardiologists from the Interventional Working Group (GACI)
of the French Society of Cardiology. A 5-years follow-up was scheduled.
Clinical characteristics, angiographic patterns and computed tomography
images, as well as the initial management of the ANOCOR cohort patients
will be presented. 
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Stents have contributed to the development of the interventional catheter-
ization of congenital heart diseases (CHD). The aim of this study was to
describe current indications and results.
Methods: Participation to this study was proposed to all catheterization
laboratories specialized in CHD in France (M3C network). All cases with
stents implantation in 2013 in pediatric and adult CHD were retrospectively
included. Adverse events were assessed using the Bergersen classification.
Risk markers were searched using univariate and multivariate analysis. 
Results: 174 stents were implanted in 127 patients. Patients were aged
15.7±15.1 year old (min 5 day-old – max 70 year-old). Main indications were
transcatheter pulmonary valve replacement (prestenting and revalvulation;
n=29 patients, 23.0%), pulmonary artery branches angioplasty (n=34, 27.0%),
aortic coarctation or recoarctation stenting (n=37, 29.4%) and ductus arteri-
osus stenting (n=11, 8.7%). 18 Patients (14.3%) were under one-year old and
35 (27.8%) were over 18 year-old. Main pathologies were tetralogy of Fallot
and variants (ACC-CHD 8.3, n=45, 35.7%), and aortic coarctation (ACC-
CHD 9.2, n=36, 28.6%). More than one stent was implanted in 32 procedures
(24.4%, max. 5 stents). Main stents implanted were the CP stent (33.0%), EV3
LD max (22.0%), Valeo (16.2%) and valved stents (15.0%). 98.5% Proce-
dures were considered as successful. Adverse events were observed in 16.7%
procedures (stent related in 12.1% procedures). Serious adverse events were
observed in 12.9%. After uni- and multivariate adjustment, only procedure
type was related to the risk of total adverse events but not to stent related
adverse events. Age, weight, center, type of stents, genetic disorder and type
of CHD were not significantly related to the risk of adverse events.
Conclusion: Stents are used in various CHD catheterization procedures,
from infancy to adult age. Adverse events rate is significant and seems related
to the type of procedure.
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Objectives: To evaluate and compare the incidence, clinical presentations
and outcomes of right-sided infective endocarditis in patients with surgical
pulmonary conduit versus those with percutaneous pulmonary valve implanta-
tion.
Methods: All consecutive patients who received a pulmonary valve surgi-
cally or percutaneously between January 2009 and June 2013 were included
and evaluated for endocarditis. 
Results: Of the 195 conduits surgically implanted (surgical group) and 93
Melody valves percutaneously implanted (PPVI group), the person-time inci-
dence rates of endocarditis were 1.2 and 3.9 cases per 100 person-years in the
surgical and PPVI groups respectively (p=0.03). Clinical presentations, micro-
biology and outcomes were comparable in both groups. The implantation-
endocarditis time interval was much shorter in the Melody valve patients
(p=0.0065). On multivariate analysis, only a past history of endocarditis was
found to significantly correlate with endocarditis (p=0.004). Probability of sur-
vival at 12, 24 and 36 months was 99.5%, 93.8%, 93.8% in the surgical-group
and 98.9%, 96.8%, 92.3% in the Melody-group respectively (p=0.6). Event
free probability including endocarditis was comparable (p=0.1). 
Conclusion: There is a high person-time incidence of endocarditis in
patients with Melody valve when compared to surgically implanted pulmonary
valves. Clinical features and microbiology were comparable in both groups.
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The possible role of the bovine jugular vein in the development of endo-
carditis is concerning. However, despite a higher incidence of Melody valve
endocarditis, probabilities of survival and event free survival were similar to
the surgical group.
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Background: Patients with corrected tetralogy of Fallot (TF) often suffer
from symptomatic right ventricular failure always associated with right bundle
branch block (RBBB) on resting ECG.
Aims: Our objective was to evaluate the mid-term safety and efficacy of
cardiac resynchronization (CRT) in this population.
Methods: We collected retrospectively every adverse events due to biven-
tricular pacing of patients with corrected tetralogy of Fallot implanted with
CRT system in our department. We also compared clinical datas (NYHA
score), stress tests, ECG, echocardiographic results before implantation, at
6 months of follow-up and at the last evaluation.
Results:From August 2005 to Septembre 2009, 9 patients were implanted
with CRT system, 6 (66,7%) with transvenous leads and 3 (33,4%) with epi-
cardic leads, mostly composed of men (6, 66,7%) with a mean age of
34,2±14,5 years, 4 (44,5%) had an Implantable Cardioverter Defibrillator
(ICD) function. During a median follow-up of 65 months [50-80], no main
adverse event was reported, we had 1 atrial lead dislogement, 3 (33%) lead
disfunctions causing only 1 (11%) resynchronisation failure and 1 (11%) inter-
mittent phrenic nerve stimulation. CRT were associated with lower NHYA
score (1,4±0,52 then 1,3±0,8 vs 2±0,4, p<0,05) and an improved exercise tol-
erance (100±21,6W then 112,9±12,9W, vs. 71,3±26,2W, p<0,05) at 6 months
and at the end of follow-up. Mean RVEF was increased (54,3±8,2 vs.
38,5±7,5; p=0,035 and so was LVEF (53,8±8,3% vs. 48,8±8,8%, p=0,04). 
Conclusion: CRT in corrected tetralogy of Fallot anad right ventricule
failure is safe and seems to be associated with an improvement of patient's
functional status. This first study on CRT in this population should be
confirmed by a large prospective randomised multicentric clinical trial.
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Congenital heart disease are frequent and often severe. Their surgical treat-
ment restores the closest possible physiological function. In Under-developing
countries, the therapeutic management of these heart disease is limited by the
lack of resources and skills. The objective of this work was to study the fate
of patients in whom the indication for surgery was raised
A retrospective descriptive study conducted at the University Hospital of
Casablanca over 5 years (décember 2008 to décember 2013). We have col-
lected 1908 patients with congenital heart disease, 738 (38.7%) had a surgical
indication. 50% of patients were operated, 22.6% non-operated. In patients
operated, the median age of surgery: 3 years [6days-51years], the median time
between diagnosis and surgery: 4months [9days-5yrs]. It was a IVC (30%)
and a IAC (20.4%). Favorable evolution in82.9%. Death occurred in15, 2%
which 62.5% immediatly in postoperative period. Mortality varied with the
centre (18% for patients operated in UHC and 24% privately center and 3.4%
in abroad). In non-operated patients, 50%were due to lack of funds, 34.3%
awaiting a surgical date and15.7% refused surgery. 34.5% of non-operated
patients died. The quality of life of survival patients is affected in 68% in
terms of physical health, and 76%of patients had mental health degradation.
Although the indication for surgery of congenital heart disease is a medical
necessity, the outcome of these patients in Moroccan context depends on
several technical and affordability considerations. This results in a high mor-
tality rate and also adult carriers of congenital heart disease with impaired
quality of life. 
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Paroxysmal supraventricular tachycardia’s (SVT) are considered of benign
if ECG in sinus rhythm (SR) is normal, but their occurrence in children/teen-
agers is always associated with an anxiousness of parents, child and doctors.
The purpose of study was to report the clinical and electrophysiological data
of children with SVT, their follow-up and management. 
Methods: 147 children and teenagers aged from 5 to 19 years (mean 15±3)
with a normal ECG in SR were studied for spontaneous SVT. Transesopha-
geal electrophysiological study was systematic. Children were followed from
1 month to 13 years (mean 2±2 years). 
Results: SVT was poorly-tolerated in 26 patients (18%). SVT was related to
atrioventricular (AV nodal re-entrant tachycardia (RT) (AVNRT) in 107 children,
either typical in 95 children or atypical AVNRT in 12 children, to an AVRT
related to a concealed accessory pathway (AP) in 40 patients (27%). Radiofre-
quency (RF) of the slow pathway (n=50) or AP (n=32) was performed in absence
of general anaesthesia in 82 patients (56%) from 1 month up to 13 years after
initial evaluation (mean 2±2 years). Failure of ablation (frequently for refuse to
continue) was frequent and occurred in 15 children (26%), 7 with AVNRT
(14%), 9 with AP (28%) (0.08). Recurrence of SVT occurred in 4 patients (5%)
and 14 (17.5%) have still sinus tachycardia-related symptoms. In 13 children
treated by antiarrhythmic drug (AAD) or betablockers, SVT recurred in 4 chil-
dren; 2 children presented AAD-related syncope. In 52 untreated patients one
death was noted after AAD infusion used to stop SVT, but other patients
remained asymptomatic or had short and well-tolerated SVT’s.
Conclusions: The management of SVT in children remains difficult
despite the development of RF ablation of SVT. Failure of ablation remains
higher than in adults for several reasons. Child remains symptomatic in 17.5%
of cases after ablation. One third of them had a spontaneous favourable evo-
lution. However in symptomatic children with frequent SVT’s despite anti-
arrhythmic drugs or betablockers, ablation should be indicated to avoid drugs-
related adverse effects.
0410
Right ventricular systolic strain evolution during peri-operative
management of congenital heart diseases
Clement Karsenty (1), Sébastien Hascoët (2), Khaled Hadeed (1), Romain
Amadieu (1), Xavier Alacoque (3), Rose Fesseau (3), Yves Dulac (1),
Sophie Breinig (4), Bertrand Leobon (2), Philippe Acar (1)
(1) CHU Toulouse, Hôpital des enfants, Pediatric cardiology, Toulouse,
France – (2) CHU Toulouse, Hôpital des enfants, Pediatric cardiac sur-
gery, Toulouse, France – (3) CHU Toulouse, Hôpital des enfants, Anes-
thésie cardiopédiatrique, Toulouse, France – (4) CHU Hôpital des
enfants, Réanimation cardiopédiatrique, Toulouse, France
Background: RV systolic strain evolution during peri-operative manage-
ment of congenital heart diseases (CHD) is unknown. 
Methods: In this prospective study, RV peak systolic strain (PSS) was
measured using 2D speckle tracking echocardiography (Qlab10.0 software,
Philips) in 39 children undergoing surgery of a CHD (Median age: 17 months,
min 6 day-old, max 14.3 year-old). Three measures were performed the day
before surgery, few hours after the surgery and before discharge and compared
